Cargando…
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609257/ https://www.ncbi.nlm.nih.gov/pubmed/30728527 http://dx.doi.org/10.1038/s41436-019-0447-8 |
| _version_ | 1783604992329908224 |
|---|---|
| author | Maruyama, Hiroki Miyata, Kaori Mikame, Mariko Taguchi, Atsumi Guili, Chu Shimura, Masaru Murayama, Kei Inoue, Takeshi Yamamoto, Saori Sugimura, Koichiro Tamita, Koichi Kawasaki, Toshihiro Kajihara, Jun Onishi, Akifumi Sugiyama, Hitoshi Sakai, Teiko Murata, Ichijiro Oda, Takamasa Toyoda, Shigeru Hanawa, Kenichiro Fujimura, Takeo Ura, Shigehisa Matsumura, Mimiko Takano, Hideki Yamashita, Satoshi Matsukura, Gaku Tazawa, Ryushi Shiga, Tsuyoshi Ebato, Mio Satoh, Hiroshi Ishii, Satoshi |
| author_facet | Maruyama, Hiroki Miyata, Kaori Mikame, Mariko Taguchi, Atsumi Guili, Chu Shimura, Masaru Murayama, Kei Inoue, Takeshi Yamamoto, Saori Sugimura, Koichiro Tamita, Koichi Kawasaki, Toshihiro Kajihara, Jun Onishi, Akifumi Sugiyama, Hitoshi Sakai, Teiko Murata, Ichijiro Oda, Takamasa Toyoda, Shigeru Hanawa, Kenichiro Fujimura, Takeo Ura, Shigehisa Matsumura, Mimiko Takano, Hideki Yamashita, Satoshi Matsukura, Gaku Tazawa, Ryushi Shiga, Tsuyoshi Ebato, Mio Satoh, Hiroshi Ishii, Satoshi |
| author_sort | Maruyama, Hiroki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7609257 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76092572020-11-05 Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis Maruyama, Hiroki Miyata, Kaori Mikame, Mariko Taguchi, Atsumi Guili, Chu Shimura, Masaru Murayama, Kei Inoue, Takeshi Yamamoto, Saori Sugimura, Koichiro Tamita, Koichi Kawasaki, Toshihiro Kajihara, Jun Onishi, Akifumi Sugiyama, Hitoshi Sakai, Teiko Murata, Ichijiro Oda, Takamasa Toyoda, Shigeru Hanawa, Kenichiro Fujimura, Takeo Ura, Shigehisa Matsumura, Mimiko Takano, Hideki Yamashita, Satoshi Matsukura, Gaku Tazawa, Ryushi Shiga, Tsuyoshi Ebato, Mio Satoh, Hiroshi Ishii, Satoshi Genet Med Correction Nature Publishing Group US 2019-02-06 2019 /pmc/articles/PMC7609257/ /pubmed/30728527 http://dx.doi.org/10.1038/s41436-019-0447-8 Text en © American College of Medical Genetics and Genomics 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Maruyama, Hiroki Miyata, Kaori Mikame, Mariko Taguchi, Atsumi Guili, Chu Shimura, Masaru Murayama, Kei Inoue, Takeshi Yamamoto, Saori Sugimura, Koichiro Tamita, Koichi Kawasaki, Toshihiro Kajihara, Jun Onishi, Akifumi Sugiyama, Hitoshi Sakai, Teiko Murata, Ichijiro Oda, Takamasa Toyoda, Shigeru Hanawa, Kenichiro Fujimura, Takeo Ura, Shigehisa Matsumura, Mimiko Takano, Hideki Yamashita, Satoshi Matsukura, Gaku Tazawa, Ryushi Shiga, Tsuyoshi Ebato, Mio Satoh, Hiroshi Ishii, Satoshi Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title | Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title_full | Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title_fullStr | Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title_full_unstemmed | Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title_short | Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis |
| title_sort | correction: effectiveness of plasma lyso-gb3 as a biomarker for selecting high-risk patients with fabry disease from multispecialty clinics for genetic analysis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609257/ https://www.ncbi.nlm.nih.gov/pubmed/30728527 http://dx.doi.org/10.1038/s41436-019-0447-8 |
| work_keys_str_mv | AT maruyamahiroki correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT miyatakaori correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT mikamemariko correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT taguchiatsumi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT guilichu correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT shimuramasaru correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT murayamakei correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT inouetakeshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT yamamotosaori correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT sugimurakoichiro correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT tamitakoichi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT kawasakitoshihiro correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT kajiharajun correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT onishiakifumi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT sugiyamahitoshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT sakaiteiko correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT murataichijiro correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT odatakamasa correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT toyodashigeru correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT hanawakenichiro correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT fujimuratakeo correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT urashigehisa correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT matsumuramimiko correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT takanohideki correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT yamashitasatoshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT matsukuragaku correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT tazawaryushi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT shigatsuyoshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT ebatomio correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT satohhiroshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis AT ishiisatoshi correctioneffectivenessofplasmalysogb3asabiomarkerforselectinghighriskpatientswithfabrydiseasefrommultispecialtyclinicsforgeneticanalysis |